Breast cancers genetic heterogeneity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Chromosomes, Human, Pair 2 Chromosomes, Human, Pair 19 Axilla Chromosomes, Human, Pair 17 Mammary Glands, Human Chromosomes, Human, Pair 1 Chromosomes, Human, Pair 16 Chromosomes, Human, Pair 3 Chromosomes, Human, Pair 6 Neoplastic Stem Cells Nipples Lymph Nodes Chromosomes, Human, Pair 8 Chromosomes, Human, Pair 5 Chromosomes, Human, Pair 11 Cell Line Chromosomes, Human, Pair 9 Chromosomes, Human, Pair 10

Organisms2

Mice, Nude Mice, SCID

Diseases40

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Genetic Predisposition to Disease Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Carcinoma Mammary Neoplasms, Experimental Disease Progression Ovarian Neoplasms Neoplasms, Hormone-Dependent Lymphatic Metastasis Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Fibrocystic Breast Disease Syndrome Prostatic Neoplasms Bone Neoplasms Colonic Neoplasms Carcinoma, Ductal Adenocarcinoma Cell Transformation, Neoplastic Genetic Diseases, Inborn Carcinoma in Situ Stomach Neoplasms Neoplasms, Second Primary Ichthyosis Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Neoplastic Syndromes, Hereditary Colorectal Neoplasms Pancreatic Neoplasms Fibroadenoma Abnormalities, Multiple Uterine Cervical Neoplasms Neovascularization, Pathologic

Chemicals and Drugs45

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Genetic Markers Tumor Markers, Biological Antineoplastic Agents, Hormonal Neoplasm Proteins Antineoplastic Agents Estrogen Receptor alpha Estrogens DNA, Neoplasm RNA, Messenger BRCA2 Protein BRCA1 Protein Aromatase Inhibitors Estrogen Antagonists Estradiol Fluorouracil RNA, Small Interfering Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Cyclophosphamide Estrogen Receptor Modulators DNA Primers Epirubicin Selective Estrogen Receptor Modulators Tumor Suppressor Protein p53 Transcription Factors Nitriles Antigens, Neoplasm Receptor, Epidermal Growth Factor DNA Tumor Suppressor Proteins RNA, Neoplasm Ki-67 Antigen Paclitaxel DNA-Binding Proteins Cancer Vaccines Antigens, CD24 Membrane Proteins Anticarcinogenic Agents Triazoles Nuclear Proteins Mucin-1

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Pedigree Mammography Prognosis Chromosome Mapping Risk Factors DNA Mutational Analysis Neoplasm Staging Early Detection of Cancer Mastectomy Case-Control Studies Polymerase Chain Reaction Chemotherapy, Adjuvant Gene Expression Profiling Risk Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Mammary Neoplasms, Experimental Disease-Free Survival Breast Self-Examination Genetic Testing Follow-Up Studies Odds Ratio Survival Rate Cohort Studies Prospective Studies Risk Assessment Retrospective Studies Oligonucleotide Array Sequence Analysis Treatment Outcome Models, Genetic Incidence Sequence Analysis, DNA Mastectomy, Segmental Sensitivity and Specificity Blotting, Western In Situ Hybridization, Fluorescence Reproducibility of Results Xenograft Model Antitumor Assays Multivariate Analysis Registries Cluster Analysis Neoplasm Transplantation Transplantation, Heterologous Ultrasonography, Mammary Genome-Wide Association Study Predictive Value of Tests Tissue Array Analysis Logistic Models Questionnaires Kaplan-Meier Estimate SEER Program Tumor Burden Models, Biological Combined Modality Therapy Breast Implants Genetic Association Studies Confidence Intervals Transfection Neoplasm Grading Immunoenzyme Techniques Mass Screening Clinical Trials as Topic Radiotherapy, Adjuvant Mammaplasty Neoadjuvant Therapy Heterozygote Detection Proportional Hazards Models Models, Statistical Drug Screening Assays, Antitumor Molecular Targeted Therapy

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Family

Phenomena and Processes76

Genetic Heterogeneity Genetic Linkage Lod Score Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Mutation Genotype Genetic Variation Phenotype Genetic Markers Genes, Dominant Genes, Recessive Genes, BRCA1 Polymorphism, Genetic Postmenopause Alleles Consanguinity Microsatellite Repeats Base Sequence Risk Haplotypes Breast Feeding Chromosomes, Human, Pair 2 Drug Resistance, Neoplasm Premenopause Exome Cell Proliferation Odds Ratio Menopause Heterozygote Homozygote Genes, BRCA2 Polymorphism, Single Nucleotide Penetrance Chromosomes, Human, Pair 19 Time Factors Genes, erbB-2 Chromosomes, Human, Pair 17 Signal Transduction Sensitivity and Specificity Chromosomes, Human, Pair 1 Germ-Line Mutation Gene Frequency Chromosomes, Human, Pair 16 Exons Polymorphism, Restriction Fragment Length Apoptosis Chromosomes, Human, Pair 3 Gene Amplification Cell Division Cell Movement Founder Effect Mutation, Missense Chromosomes, Human, Pair 6 Loss of Heterozygosity Phylogeny Amino Acid Sequence Down-Regulation Promoter Regions, Genetic DNA Methylation Gene Expression Genome, Human Chromosomes, Human, Pair 8 Chromosomes, Human, Pair 5 Transfection Cell Growth Processes Polymorphism, Single-Stranded Conformational Cell Cycle Dose-Response Relationship, Drug Chromosomes, Human, Pair 11 RNA Interference Up-Regulation Parity Chromosomes, Human, Pair 9 Cell Survival Chromosomes, Human, Pair 10

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Information Science9

Molecular Sequence Data Base Sequence Survival Rate Incidence Registries Questionnaires Phylogeny Amino Acid Sequence SEER Program

Named Groups4

Survivors European Continental Ancestry Group Jews Asian Continental Ancestry Group

Health Care35

Risk Factors Case-Control Studies Risk Survival Analysis Family Health Disease-Free Survival Genetic Testing Age Factors Follow-Up Studies Odds Ratio Survival Rate Age of Onset Cohort Studies Prospective Studies Risk Assessment Retrospective Studies Treatment Outcome Incidence Sensitivity and Specificity Reproducibility of Results Multivariate Analysis Registries Cluster Analysis Genome-Wide Association Study Predictive Value of Tests Logistic Models Questionnaires Kaplan-Meier Estimate SEER Program Confidence Intervals Mass Screening Clinical Trials as Topic Parity Proportional Hazards Models Models, Statistical

Geographicals3

United States Italy China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Genetic Heterogeneity Breast Breast Neoplasms Pedigree Carcinoma, Ductal, Breast Genetic Linkage Receptors, Estrogen Lod Score Cell Line, Tumor Receptor, erbB-2 Breast Diseases Tamoxifen Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Receptors, Progesterone Mutation Genotype Mammography Genetic Variation Prognosis Phenotype Neoplasm Metastasis Genetic Markers Chromosome Mapping Neoplasm Invasiveness Tumor Markers, Biological Risk Factors Breast Neoplasms, Male Antineoplastic Agents, Hormonal DNA Mutational Analysis Neoplasm Proteins Genes, Dominant Neoplasm Staging Early Detection of Cancer Mastectomy Case-Control Studies Antineoplastic Agents Genes, Recessive Genes, BRCA1 Polymorphism, Genetic Postmenopause Alleles Polymerase Chain Reaction Molecular Sequence Data Chemotherapy, Adjuvant Carcinoma, Lobular Gene Expression Profiling Consanguinity Carcinoma, Intraductal, Noninfiltrating Microsatellite Repeats MCF-7 Cells Base Sequence Risk Mice, Nude Haplotypes Tumor Cells, Cultured Breast Feeding Survival Analysis Chromosomes, Human, Pair 2 Reverse Transcriptase Polymerase Chain Reaction Drug Resistance, Neoplasm Premenopause Antineoplastic Combined Chemotherapy Protocols Estrogen Receptor alpha Carcinoma Estrogens Immunohistochemistry Exome Mammary Neoplasms, Experimental Family Health DNA, Neoplasm Disease-Free Survival Breast Self-Examination Disease Progression Ovarian Neoplasms Neoplasms, Hormone-Dependent Genetic Testing Lymphatic Metastasis Cell Proliferation RNA, Messenger Age Factors Follow-Up Studies Neoplasms Neoplasm Recurrence, Local Odds Ratio Menopause BRCA2 Protein Survival Rate Age of Onset Heterozygote Cohort Studies Prospective Studies Homozygote Risk Assessment BRCA1 Protein Genes, BRCA2 Lung Neoplasms Polymorphism, Single Nucleotide Penetrance Chromosomes, Human, Pair 19

No FAQ available that match "breast cancers genetic heterogeneity"